Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gallstone recurrence after successful lithotripsy

G Pelletier1, J M Raymond, R Capdeville

  • 1Hôpital de Bicêtre, Le Kremlin Bicêtre, France.

Journal of Hepatology
|October 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does enhanced recovery improve the survival rates of patients 3 years after undergoing surgery to remove a tumor in the colon?

International journal of colorectal disease·2018
Same author

The combination of everolimus and zoledronic acid increase the efficacy of gemcitabine in a mouse model of pancreatic adenocarcinoma.

Oncotarget·2018
Same author

Human papillomavirus does not play a role in the Barrett esophagus: a French cohort.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2017
Same author

Phase II study of paclitaxel combined with capecitabine as second-line treatment for advanced gastric carcinoma after failure of cisplatin-based regimens.

Cancer chemotherapy and pharmacology·2009
Same author

Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402).

European journal of cancer (Oxford, England : 1990)·2008
Same author

Endoscopic argon plasma trimming of biliary and gastrointestinal metallic stents.

Endoscopy·2005
Same journal

Moving Too Fast? A Meta-Analysis Calls for Caution on TNF Inhibitors as First-Line Therapy for Autoimmune Hepatitis.

Journal of hepatology·2026
Same journal

Anserine restores antibacterial immunity in cirrhosis via a protective CCL5-mediated hepatocyte-CD44<sup>+</sup>pDC crosstalk.

Journal of hepatology·2026
Same journal

Anti-CCL2-conjugated platelets attenuate early allograft and ischemia-reperfusion injury by inhibiting monocyte infiltration.

Journal of hepatology·2026
Same journal

A precision randomized trial of hepatitis C treatment support among people who inject drugs in India: The STOP-C Trial.

Journal of hepatology·2026
Same journal

Response to "Single-nucleus and spatial transcriptomic analyses reveal intra-tissue heterogeneity of PNPLA3".

Journal of hepatology·2026
Same journal

One-stop liquid biopsy: Can a single blood sample reveal the full spectrum of liver disease?

Journal of hepatology·2026
See all related articles

Gallstone recurrence after lithotripsy is lower than expected, especially for patients with solitary stones. This study tracked recurrence rates over five years, finding significantly fewer recurrences in single-stone cases.

Area of Science:

  • Gastroenterology
  • Hepatobiliary Surgery
  • Medical Technology

Background:

  • Gallstone recurrence after treatment poses a clinical challenge.
  • Lithotripsy is a common treatment for gallstones.
  • Understanding long-term recurrence rates is crucial for patient management.

Purpose of the Study:

  • To determine the gallstone recurrence rate within five years following successful lithotripsy.
  • To compare recurrence rates between patients with solitary versus multiple gallstones.

Main Methods:

  • A prospective study followed 150 patients after gallstone clearance via lithotripsy.
  • Patients were monitored for a median of 42 months (range 6-72 months).
  • No preventative therapies were administered; recurrence was assessed over five years.

Related Experiment Videos

Main Results:

  • Thirty-seven patients (24.7%) developed recurrent gallstones within five years.
  • Recurrence probabilities at 1, 2, 3, 4, and 5 years were 6.6%, 15.7%, 22.8%, 29.7%, and 32.2%, respectively.
  • Recurrence rates were significantly lower in solitary stone patients (26.1%) compared to multiple stone patients (47%) at 5 years (p<0.009).
  • Only 14% of patients with recurrence experienced symptoms or complications.

Conclusions:

  • Gallstone recurrence after lithotripsy is lower than suggested by dissolution studies.
  • Solitary gallstones have a considerably lower recurrence rate post-lithotripsy.
  • Long-term monitoring and patient stratification based on stone type are important.